Combined iron/folic acid supplements and malaria prophylaxis reduce neonatal mortality in 19 sub-Saharan African countries

American Journal of Clinical Nutrition

Volumn 92, Issue 1, 2010, Pages 235-243

  Titaley, Christiana R ^a   Dibley, Michael J ^a   Roberts, Christine L ^b   Agho, Kingsley ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; FOLIC ACID; IRON; PYRIMETHAMINE PLUS SULFADOXINE; TETANUS TOXOID;

ADULT; AFRICA; ARTICLE; BIRTH ORDER; CONTROLLED STUDY; DELIVERY; DEMOGRAPHY; DIET SUPPLEMENTATION; DOSE RESPONSE; ENDEMIC DISEASE; FAMILY PLANNING; FEMALE; HEALTH SURVEY; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALARIA; MALARIA CONTROL; MALE; MARRIAGE; MATERNAL AGE; NEWBORN MORTALITY; PREDICTION; SEX DIFFERENCE; SMALL FOR DATE INFANT; SURVIVAL; AFRICA SOUTH OF THE SAHARA; CHILD HEALTH CARE; HEALTH CARE DELIVERY; HEALTH SERVICE; INFANT MORTALITY; NEWBORN; PREGNANCY; STANDARD;

AFRICA SOUTH OF THE SAHARA; CHILD HEALTH SERVICES; DELIVERY OF HEALTH CARE; DEMOGRAPHY; DIETARY SUPPLEMENTS; FEMALE; FOLIC ACID; HEALTH SURVEYS; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; IRON; MALARIA; MALE; MATERNAL HEALTH SERVICES; PREGNANCY;

EID: 77954591528     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.2009.29093     Document Type: Article

References (44)

1. Lawn JE, Cousens S, Zupan J, Lancet Neonatal Survival Steering Team. 4 million neonatal deaths: When? Where? Why? Lancet 2005;365:891-900.
2. Lawn J, Kerber K, eds. Opportunities for Africa's newborns: practical data, policy and programmatic support for newborn care in Africa. Cape Town, South Africa: WHO on behalf of The Partnership for Maternal Newborn and Child Health, 2006
3. Steketee RW, Nahlen BL, Parise ME, Menendez C. The burden of malaria in pregnancy in malaria-endemic areas. Am J Trop Med Hyg 2001;64:28-35. (Pubitemid 32552569)
4. Brabin B. The risks and severity of malaria in pregnant women. Applied Field Research in Malaria Reports, No. 1. Geneva, Switzerland: World Health Organization, 1991.
5. Brabin BJ. An analysis of malaria in pregnancy in Africa. Bull World Health Organ 1983;61:1005-16.
6. Levy A, Fraser D, Katz M, Mazor M, Sheiner E. Maternal anemia during pregnancy is an independent risk factor for low birthweight and preterm delivery. Eur J Obstet Gynecol Reprod Biol 2005;122:182-6.
7. World Health Organization. A strategic framework for malaria prevention and control during pregnancy in the African region. Brazzaville, Congo: WHO Regional Office for Africa, 2004.
8. World Health Organization, Unicef. Africa malaria report 2003. Geneva, Switzerland: World Health Organization/Unicef, 2003.
9. Parise ME, Ayisi JG, Nahlen BL, et al. Efficacy of sulfadoxinepyrimethamine for prevention of placental malaria in an area of Kenya with a high prevalence of malaria and human immunodeficiency virus infection. Am J Trop Med Hyg 1998;59:813-22.
10. De Mayer EM. Preventing and controlling iron deficiency anemia through primary health care: a guide for health administrators and programme managers. Geneva, Switzerland: World Health Organization, 1989.
11. Pena-Rosas JP, Viteri FE. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database Syst Rev 2006;3:CD004736.
12. Zeng L, Dibley MJ, Cheng Y, et al. Impact of micronutrient supplementation during pregnancy on birth weight, duration of gestation and perinatal mortality in rural western China: double-blind cluster randomised controlled trial. BMJ 2008;337:a2001.
13. Cogswell ME, Parvanta I, Ickes L, Yip R, Brittenham GM. Iron supplementation during pregnancy, anemia, and birth weight: a randomized controlled trial. Am J Clin Nutr 2003;78:773-81.
14. Siega-Riz AM, Hartzema AG, Turnbull C, Thorp J, McDonald T, Cogswell ME. The effects of prophylactic iron given in prenatal supplements on iron status and birth outcomes: A randomized controlled trial. Am J Obstet Gynecol 2006;194:512-9.
15. Titaley CR, Dibley MJ, Roberts CL, Hall J, Agho K. Iron and folic acid supplements and reduced early neonatal deaths in Indonesia. WHO Bulletin, 2009. Available from: http://www.who.int/bulletin/volumes/88/7/09-065813.pdf (cited 29 December 2009).
16. Smith AW, Hendrickse RG, Harrison C, Hayes RJ, Greenwood BM. The effects on malaria of treatment of iron-deficiency anaemia with oral iron in Gambian children. Ann Trop Paediatr 1989;9:17-23.
17. Oppenheimer SJ, Macfarlane SB, Moody JB, Harrison C. Total dose iron infusion, malaria and pregnancy in Papua New Guinea. Trans R Soc Trop Med Hyg 1986;80:818-22.
18. Oppenheimer SJ. Iron and its relation to immunity and infectious disease. J Nutr 2001;131:616S-35S.
19. Kabyemela ER, Fried M, Kurtis JD, Mutabingwa TK, Duffy PE. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J Infect Dis 2008;198:163-6.
20. Ojukwu JU, Okebe JU, Yahav D, Paul M. Oral iron supplementation for preventing or treating anaemia among children in malaria-endemic areas. Cochrane Database Syst Rev 2009;3:CD006589.
21. Menendez C, Todd J, Alonso PL, et al. The effects of iron supplementation during pregnancy, given by traditional birth attendants, on the prevalence of anaemia and malaria. Trans R Soc Trop Med Hyg 1994;88:590-3.
22. Rutstein SO, Rojas G. Guide to DHS statistics. Calverton, MD: ORC Macro, 2006.
23. Macro International Inc. Measure DHS: demographic and health surveys. Available from: http://www.measuredhs.com/countries/browse-country.cfm?selected= 2 (cited 7 May 2009).
24. Macro International Inc. Sampling manual. DHS-III basic documentation no. 6. Calverton, MD: Macro International Inc, 1996.
25. Mosley WH, Chen LC. An analytical framework for the study of child survival in developing countries. Popul Dev Rev 1984;10(suppl):25-45.
26. Filmer D, Pritchett LH. Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 2001;38:115-32.
27. Poerwanto S, Stevenson M, de Klerk N. Infant mortality and family welfare: policy implications for Indonesia. J Epidemiol Community Health 2003;57:493-8.
28. Razzaque A, Streatfield P, Gwatkin D. Does health intervention improve socioeconomic inequalities of neonatal, infant and child mortality? Evidence from Matlab, Bangladesh. Int J Equity Health 2007;6:4.
29. Jekel JF, Katz DL, Elmore JG. Epidemiology, biostatistics, and preventive Medicine. 2nd ed. Philadelphia, PA: WB Saunders Company, 2001.
30. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88:15-9.
31. Ngoc NT, Merialdi M, Abdel-Aleem H, et al. Causes of stillbirths and early neonatal deaths: data from 7993 pregnancies in six developing countries. Bull World Health Organ 2006;84:699-705.
32. Dallman PR. Biochemical basis for the manifestations of iron deficiency. Annu Rev Nutr 1986;6:13-40.
33. Mburu ASW, Thurnham DI, Mwaniki DL, Muniu EM, Alumasa F, de Wagt A. The influence and benefits of controlling for inflammation on plasma ferritin and hemoglobin responses following a multimicronutrient supplement in apparently healthy, HIV+ Kenyan adults. J Nutr 2008;138:613-9.
34. Greenwood R, Golding J, McCaw-Binns A, Keeling J, Ashley D. The epidemiology of perinatal death in Jamaica. Paediatr Perinat Epidemiol 1994;8:143-57.
35. Shulman CE, Dorman EK, Cutts F, et al. Intermittent sulphadoxinepyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial. Lancet 1999;353:632-6.
36. Stoltzfus RJ. Summary: implications for research and programs. J Nutr 2001;131:697S-701S.
37. Daily JP, Wylie BJ. Iron deficiency during pregnancy: blessing or curse? J Infect Dis 2008;198:157-8.
38. Thurnham D. Handling data when inflammation is detected. Sight and Life 2008:49-52.
39. Thurnham DI, Mburu ASW, Mwaniki DL, Wagt AD. Micronutrients in childhood and the influence of subclinical inflammation. Proc Nutr Soc 2005;64:502-9.
40. Ouma P, Parise ME, Hamel MJ, et al. A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine. PLoS Clin Trials 2006;1:e28.
41. Carter JY, Loolpapit MP, Lema OE, Tome JL, Nagelkerke NJD, Watkins WM. Reduction of the efficacy of antifolate antimalarial therapy by folic acid supplementation. Am J Trop Med Hyg 2005;73:166-70.
42. Mbaye A, Richardson K, Balajo B, et al. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae. Am J Trop Med Hyg 2006;74:960-4.
43. Hall S. Neonatal mortality in developing countries: what can we learn from DHS data? Applications & Policy Working Paper A05/02. Southampton, UK: University of Southampton, Statistical Sciences Research Institute, 2005.
44. Hill K, Choi Y. Neonatal mortality in the developing world. Demogr Res 2006;14:429-52.